Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

The ready-to-use autoinjector emergency glucagon pen is now available for people over the age of two in the US
Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications
The diaTribe team attended the 2020 ADA 80th Scientific Sessions to share several of the greatest highlights from the virtual conference!
ADA 2020 is officially in the books! Here are some more of our highlights from the last day and a half of ADA’s virtual 80th Scientific Sessions: Teplizumab, Control-IQ...
Check out the third day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on off label use in type 1 diabetes, type 2 diabetes remission,...
Check out the second day highlights from ADA’s virtual 80th Scientific Sessions – including new insights on Farxiga for diabetes prevention, soda taxes, the gut...
Michael Hattori, who has type 2 diabetes, shares several questions that you may consider asking your healthcare team when you are first diagnosed
Sanofi is giving access to a 30-day supply of medicine for those waiting for their Patient Connection program application to be processed
Newly diagnosed with type 2 diabetes? Dr. Francine Kaufman answers some of the most commonly asked questions for teens with type 2 diabetes
Learn how you can get affordable insulin without insurance coverage
Stefany Shaheen shares her daughter’s story of diabetic ketoacidosis and the hospital’s response, and her takeaways from this experience
Nurse and diabetes educator (and person with type 2 diabetes in remission!) Michael Hattori introduces seven self-care behaviors that provide a foundation for managing...
States have been working furiously during the COVID-19 pandemic to limit monthly out-of-pocket expenses on insulin
Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes
People using Novo Nordisk insulin who have lost health insurance coverage due to job loss during COVID-19 are eligible for free insulin for 90 days
With unemployment rising, Lilly’s Insulin Value Program limits insulin prescription costs to $35 a month for people who are uninsured or who have commercial insurance
Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on...
Make sure that you have, and are able to access, insulin during the coronavirus pandemic. Here are tips to stay prepared
Early trial results found that SGLT-2 inhibitor Farxiga is highly effective for preventing and treating kidney disease in people with or without type 2 diabetes
By Jimmy McDermott Lilly does not expect any medication shortages during the coronavirus pandemic, and reminds people with diabetes about cost saving programs for...

Pages